10041: Navitoclax Modulates Interleukin-3-Induced Endothelial Cells Angiogenesis
Nur Najmi Mohamad Anuar +5 more
openaire +1 more source
BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer. [PDF]
DeStefanis RA +24 more
europepmc +1 more source
BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting. [PDF]
Silva JPN +3 more
europepmc +1 more source
Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics. [PDF]
Sreeram I +6 more
europepmc +1 more source
Pharmacological clearance of senescent cells reduces inflammation, endothelial damage and cardiac fibrosis in HFpEF. [PDF]
Silva ED +28 more
europepmc +1 more source
Distinct cMET inhibitors uncover pharmacological heterogeneity in SHH medulloblastoma cell lines. [PDF]
Morlando S +6 more
europepmc +1 more source
Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cells. [PDF]
Bywater MJ +9 more
europepmc +1 more source
Senogenic-senolytic treatment strategies enhance tumor control and can improve survival in murine cancer models: a systematic review. [PDF]
Hamburger ECB +3 more
europepmc +1 more source
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors. [PDF]
ElHarouni D +16 more
europepmc +1 more source

